| David G Wirtshafter, MD | |
|
1500 Saint Georges Ave, Avenel, NJ 07001-1000 | |
| (732) 381-8686 | |
| (732) 499-7724 |
| Full Name | David G Wirtshafter |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 35 Years |
| Location | 1500 Saint Georges Ave, Avenel, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225035785 | NPI | - | NPPES |
| 6208207 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 25MA06690100 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayshore Medical Center | Holmdel, NJ | Hospital |
| Jfk Medical Center | Edison, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Imaging Llc | 8123312055 | 47 |
| Health Village Imaging Llc | 9537263223 | 23 |
| The New Jersey Imaging Network, Llc | 2860633492 | 64 |
News Archive
A new study by investigators at Brigham and Women's Hospital has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated with a 1.6-fold increased risk of death.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced preclinical results demonstrating the effectiveness of KAI-1678 in reversing pain (hyperalgesia and allodynia) in multiple preclinical models.
A UCLA study has identified a way to turn off a key signaling pathway involved in physiological processes that can also stimulate the development of cancer and other diseases. The findings may lead to new treatments and targeted drugs using this approach.
A state advisory group on Thursday recommended legislative changes to bolster oversight of coronary stent placements amid widespread concerns about unnecessary medical procedures, but it stopped short of proposing that state law regulate physician reviews in hospitals.
› Verified 2 days ago
| Entity Name | Avenel Iselin Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487674867 PECOS PAC ID: 5597751941 Enrollment ID: O20040422000098 |
News Archive
A new study by investigators at Brigham and Women's Hospital has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated with a 1.6-fold increased risk of death.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced preclinical results demonstrating the effectiveness of KAI-1678 in reversing pain (hyperalgesia and allodynia) in multiple preclinical models.
A UCLA study has identified a way to turn off a key signaling pathway involved in physiological processes that can also stimulate the development of cancer and other diseases. The findings may lead to new treatments and targeted drugs using this approach.
A state advisory group on Thursday recommended legislative changes to bolster oversight of coronary stent placements amid widespread concerns about unnecessary medical procedures, but it stopped short of proposing that state law regulate physician reviews in hospitals.
› Verified 2 days ago
| Entity Name | Health Village Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194810978 PECOS PAC ID: 9537263223 Enrollment ID: O20070406000359 |
News Archive
A new study by investigators at Brigham and Women's Hospital has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated with a 1.6-fold increased risk of death.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced preclinical results demonstrating the effectiveness of KAI-1678 in reversing pain (hyperalgesia and allodynia) in multiple preclinical models.
A UCLA study has identified a way to turn off a key signaling pathway involved in physiological processes that can also stimulate the development of cancer and other diseases. The findings may lead to new treatments and targeted drugs using this approach.
A state advisory group on Thursday recommended legislative changes to bolster oversight of coronary stent placements amid widespread concerns about unnecessary medical procedures, but it stopped short of proposing that state law regulate physician reviews in hospitals.
› Verified 2 days ago
| Entity Name | The New Jersey Imaging Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629327887 PECOS PAC ID: 2860633492 Enrollment ID: O20130724000791 |
News Archive
A new study by investigators at Brigham and Women's Hospital has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated with a 1.6-fold increased risk of death.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced preclinical results demonstrating the effectiveness of KAI-1678 in reversing pain (hyperalgesia and allodynia) in multiple preclinical models.
A UCLA study has identified a way to turn off a key signaling pathway involved in physiological processes that can also stimulate the development of cancer and other diseases. The findings may lead to new treatments and targeted drugs using this approach.
A state advisory group on Thursday recommended legislative changes to bolster oversight of coronary stent placements amid widespread concerns about unnecessary medical procedures, but it stopped short of proposing that state law regulate physician reviews in hospitals.
› Verified 2 days ago
| Entity Name | Coastal Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710334727 PECOS PAC ID: 8123312055 Enrollment ID: O20160816000083 |
News Archive
A new study by investigators at Brigham and Women's Hospital has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated with a 1.6-fold increased risk of death.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced preclinical results demonstrating the effectiveness of KAI-1678 in reversing pain (hyperalgesia and allodynia) in multiple preclinical models.
A UCLA study has identified a way to turn off a key signaling pathway involved in physiological processes that can also stimulate the development of cancer and other diseases. The findings may lead to new treatments and targeted drugs using this approach.
A state advisory group on Thursday recommended legislative changes to bolster oversight of coronary stent placements amid widespread concerns about unnecessary medical procedures, but it stopped short of proposing that state law regulate physician reviews in hospitals.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David G Wirtshafter, MD 1500 Saint Georges Ave, Avenel, NJ 07001-1000 Ph: (732) 381-8686 | David G Wirtshafter, MD 1500 Saint Georges Ave, Avenel, NJ 07001-1000 Ph: (732) 381-8686 |
News Archive
A new study by investigators at Brigham and Women's Hospital has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated with a 1.6-fold increased risk of death.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced preclinical results demonstrating the effectiveness of KAI-1678 in reversing pain (hyperalgesia and allodynia) in multiple preclinical models.
A UCLA study has identified a way to turn off a key signaling pathway involved in physiological processes that can also stimulate the development of cancer and other diseases. The findings may lead to new treatments and targeted drugs using this approach.
A state advisory group on Thursday recommended legislative changes to bolster oversight of coronary stent placements amid widespread concerns about unnecessary medical procedures, but it stopped short of proposing that state law regulate physician reviews in hospitals.
› Verified 2 days ago
Edward S Rittweger, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
Leo J Fontana, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
Mark Singer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
Charles A Saniewski, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
Dr. Peter S Doss, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-574-8999 Fax: 732-574-3488 | |
Robert Bashkim Limani, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 |